Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two 4% articaine formulations with epinephrine for maxillary third molar extraction
RBR-4nj2b8rNot yet recruiting
- Sponsor
- Universidade Iguaçu
- Start
- Jul 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of articaine and epinephrine in Impacted maxillary third molar (2 arms), sponsored by Universidade Iguaçu. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
articaineepinephrine
03
Conditions
Impacted maxillary third molar
Beyond the preview
Go deeper on RBR-4nj2b8r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4nj2b8r.